Post-approval studies (Phase 4)Study completedNCT00082277
What this trial is testing
Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer
Who this might be right for
Breast Cancer
AstraZeneca 237